CDBT — China Dasheng Biotechnology Co Cashflow Statement

0.000.00%

Last trade - 00:00

FinancialsHighly SpeculativeMicro Cap

Annual cashflow statement for China Dasheng Biotechnology Co, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

	2005 October 31st	2006 October 31st	2007 October 31st	2008 June 30th
Period Length:	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	10KSB	10-K
Standards:	USG	USG	USG	USG
Status:	Final	Final	Final	Final
Net Income/Starting Line	-0.023	-0.017	-0.068	4.64
Depreciation
Non-Cash Items	—	—	—	0.616
Other Non-Cash Items
Changes in Working Capital	0.022	0.021	0.051	-1.78
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Cash from Operating Activities	0.001	0.006	-0.015	4.1
Capital Expenditures	—	—	—	-0.031
Purchase of Fixed Assets
Other Investing Cash Flow Items	—	—	0.008	-3.89
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities	—	—	0.008	-3.92
Financing Cash Flow Items	—	—	—	0.177
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	—	—	0.001	-0.927
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	0.001	0.006	-0.007	0.245